Lung Cancer Clinical Trial

Clinical Trial Finder Lung Cancer Trials

An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer

See Locations Near You

Summary

The purpose of this study is to determine whether Nivolumab, in combination with other therapies, is effective in patients with advanced Non-Small Cell lung cancer

View Eligibility Criteria

Eligibility Criteria

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

Advanced Non Small Cell Lung Cancer (NSCLC)
Eastern Cooperative Oncology Group (ECOG) Performance status of ≤ 1
Life expectancy of at least 3 months from most recent chemotherapy or immunotherapy treatment
Must have at least 1 lesion with measurable disease

Exclusion Criteria:

Subjects with certain mutations that have not been treated with a targeted therapy prior to enrollment
Subjects who need daily oxygen therapy
People with autoimmune disease

Other protocol defined inclusion/exclusion criteria could apply

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

295

Study ID:

NCT02750514

Recruitment Status:

Terminated

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 48 Locations for this study

See Locations Near You

City of Hope National Medical Center
Duarte California, 91010, United States
University of Southern California (USC)
Los Angeles California, 90033, United States
Cedars-Sinai Medical Center
Los Angeles California, 90048, United States
University of Californa, Los Angeles (UCLA)
Los Angeles California, 90095, United States
Hoag Memorial Hospital Presbyterian
Newport Beach California, 92658, United States
University of California San Diego
San Diego California, 92122, United States
University of Colorado Denver
Aurora Colorado, 80045, United States
Yale Cancer Center
New Haven Connecticut, 06511, United States
University of Kansas Cancer Center
Westwood Kansas, 66205, United States
University of Maryland - Marlene and Stewart Greenebaum Cancer Center
Baltimore Maryland, 21201, United States
Sidney Kimmel Comprehensive Cancer Center
Baltimore Maryland, 21287, United States
Massachusetts General Hospital
Boston Massachusetts, 02114, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States
Dana Farber/Harvard Cancer Center
Boston Massachusetts, 02215, United States
University of Michigan Health System (UMHS) - University Hospital (University of Michigan Medical Ce
Ann Arbor Michigan, 48109, United States
Karmanos Cancer Institute
Detroit Michigan, 48201, United States
Washington University, The Center for Advanced Medicine
Saint Louis Missouri, 63110, United States
Comprehensive Cancer Centers of Nevada
Las Vegas Nevada, 89119, United States
Roswell Park Cancer Institute
Buffalo New York, 14263, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Univ of NC Shool of Medicine
Chapel Hill North Carolina, 27514, United States
The Ohio State University
Columbus Ohio, 43210, United States
Northwest Cancer Specialists
Portland Oregon, 97225, United States
Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States
Fox Chase Cancer Center
Philadelphia Pennsylvania, 19111, United States
University of Pittsburgh Medical Center
Pittsburgh Pennsylvania, 15217, United States
The West Clinic, P.C. d/b/a West Cancer Center
Germantown Tennessee, 38138, United States
Sarah Cannon Cancer Center
Nashville Tennessee, 37203, United States
Sammons Cancer Center (Uso)
Dallas Texas, 75246, United States
Texas Oncology, P.A.
Fort Worth Texas, 76104, United States
The University of Texas MD Anderson Cancer Center
Houston Texas, 77030, United States
Us Oncology
Tyler Texas, 75702, United States
Huntsman Cancer Institute
Salt Lake City Utah, 84112, United States
Virginia Cancer Specialists, PC
Fairfax Virginia, 22031, United States
University of Washington-Seattle Cancer Care Alliance
Seattle Washington, 98109, United States
Local Institution
Clayton Victoria, , Australia
Local Institution
Salzburg , 5020, Austria
Juravinski Cancer Centre, Hamilton Health Sciences-Mcmaster Univeristy's Faculty Of Health Sciences
Hamilton Ontario, L8V 5, Canada
University Of Ottawa - The Ottawa Hospital Cancer centre
Ottawa Ontario, K1H 8, Canada
Local Institution
Edmonton , T6G 1, Canada
Local Institution
Paris , 75005, France
Local Institution
Toulouse , 31059, France
Local Institution
Villejuif Cedex , 94805, France
Local Institution
Milano , 20132, Italy
Local Institution
Milan , 20141, Italy
Local Institution
Rozzano , 20089, Italy
Local Institution
Madrid , 28041, Spain
Local Institution
Madrid , 28050, Spain
Local Institution
Pamplona , 31008, Spain
Local Institution
Lausanne , CH-10, Switzerland
Load More

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

295

Study ID:

NCT02750514

Recruitment Status:

Terminated

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
When Should I Consider Clinical Trials?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider